Skip to main content
. 2017 Feb 28;31(4):289–305. doi: 10.1007/s40263-017-0415-2

Fig. 3.

Fig. 3

Mean percentage change in BV (measured with SIENA) from baseline (core FREEDOMS and FREEDOMS II) in the continuous and switched groups of patients participating in the LONGTERMS extension study [34]. In the switched groups, patients were switched from placebo to fingolimod at month 24. BV brain volume, SIENA Structural Image Evaluation, using Normalization, of Atrophy